CLASS II ONGOING Device recall · Reported 22 Jul 2026 · FDA Enforcement Report

ST Aia-Pack Testosterone, IN Vitro Diagnostic Use Only recalled

Tosoh Bioscience is recalling ST Aia-Pack Testosterone, IN Vitro Diagnostic Use Only for the quantitative measurement, distributed nationwide in the US. The recall was initiated on 12 Jun 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 14560189210032; Lot Numbers: FX12404, FY12407, FY12406, FZ12408
Quantity recalled310 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2746-2026
FDA event ID
99210
Recalling firm
Tosoh Bioscience, Grove City, OH
Classification
Class II
Status
Ongoing
Recall initiated
12 Jun 2026
FDA classified
16 Jul 2026
Reported
22 Jul 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

12 Jun 2026Recall initiated by company
16 Jul 2026Classified by FDA+34 days
22 Jul 2026Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The Test cup lot F level 1 low-quality control results values for the device were lower than expected on the Automated Immunoassay Analyzer (AIA) which could cause falsely elevated or falsely low total testosterone results. Such erroneous test results may lead to additional testing/diagnostic interventions and in limited cases, may lead to a delay in diagnosis and/or initiation of unnecessary or incorrect clinical treatment measures.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

ST AIA-Pack Testosterone, IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of testosterone in human serum on specific Tosoh AIA System analyzers, Model Number 0025204

Where it was distributed

Global Distribution. US Nationwide.

Nationwide

Questions about this recall

Why was it recalled?

The Test cup lot F level 1 low-quality control results values for the device were lower than expected on the Automated Immunoassay Analyzer (AIA) which could cause falsely elevated or falsely low total testosterone results. Such erroneous test results may lead to additional testing/diagnostic interventions and in limited cases, may lead to a delay in diagnosis and/or initiation of unnecessary or incorrect clinical treatment measures.

Which lots are affected?

UDI-DI: 14560189210032; Lot Numbers: FX12404, FY12407, FY12406, FZ12408

Where was it sold?

Global Distribution. US Nationwide.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Tosoh Bioscience

All 74

Other Test Kits & Diagnostics recalls

All 2,658